İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2025

Importance of 18F-fluorodeoxyglucose positron emission tomography/computed tomography heterogeneity indices in non-small cell lung cancer

Dergi

Revista da Associação Médica Brasileira

ISSN 0104-4230

ISSN kaydı başka bir dergiye işaret ediyor; ad YÖKSİS kaydından.

YÖKSİS OpenAlex Açık erişim · diamond SJR Q3 JCR Q2 Atıf 2 Yüzdelik 78.6% FWCI 1.25
Yıl
2025
Tür
article

Veri kaynağı ayrımı

  • YÖKSİS YÖKSİS makale kaydı
  • YÖKSİS dergi adı Revista da Associação Médica Brasileira
  • Katalog eşleşmesi (ISSN) Revista da Associacao Medica Brasileira
  • OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

OpenAlex · İngilizce

OBJECTIVE: The aim of this study was to assess the relationship between metabolic tumor heterogeneity indices in patients with driver mutation-positive non-small cell lung cancer, with a particular focus on the impact of heterogeneity indices on prognostic outcomes. METHODS: Patients diagnosed with metastatic small-cell lung cancer with driver mutations were included in this study. The relationship between the patients' 18F-fluorodeoxyglucose positron emission tomography/computed tomography parameters and heterogeneity indices and survival was examined. RESULTS: Heterogeneity index-1 values greater than 0.29 were associated with an increased likelihood of mortality (61.7% in the exitus group compared to 28% in the survivor group, p=0.006). Lower heterogeneity index-2 values were more prevalent among the exitus group, with a statistically significant difference observed between the groups (55.3% in the exitus group versus 24% in the survivor group, p=0.010). The mean overall survival time was longer in patients with low heterogeneity index-1 levels (p=0.006). The mean overall survival time was found to be similar between the heterogeneity index-2 level groups (p=0.672). CONCLUSION: 18F-fluorodeoxyglucose positron emission tomography/computed tomography metabolic tumor heterogeneity indices are an important tool for predicting the prognosis of non-small cell lung cancer patients with driver mutations.

Konular

Atıflar

OpenAlex cited_by_count. WoS veya Scopus atıf sayısı değildir; o kaynaklar için ayrı kolon yoktur.

2 atıf

OpenAlex cited_by_count (önbellek / veritabanı)

Yazarlar

  1. ALİ OĞUL MERSİN ÜNİVERSİTESİ
  2. İlhan Birsenoğul
  3. AYGÜL POLAT
  4. ALİ ALPER SOLMAZ
  5. YUNUS COŞKUN
  6. ABDULLAH EVREN YETİŞİR
  7. BERNA BOZKURT DUMAN
  8. TİMUÇİN ÇİL